• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于抗炎活性的渗透控制型粘膜粘附杯芯(OCMC)片剂的研制

Development of Osmotically Controlled Mucoadhesive Cup-Core (OCMC) Tablet for The Anti-Inflammatory Activity.

作者信息

Ranchhodbhai Patel Hitesh, Manordas Patel Madhabhai

机构信息

Department of Pharmaceutical Technology, S. K. Patel College of Pharmaceutical Education and Research, Ganpat University, Gujarat, India.

出版信息

Iran J Pharm Res. 2010 Winter;9(1):21-6.

PMID:24363702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3869558/
Abstract

The aim of the present study was to prepare and evaluate an osmotically controlled mucoadhesive cup-core (OCMC) containing aceclofenac. A special technique was used while preparing an OCMC. Stability of OCMC was determined in natural human saliva, and it was found that both pH and device are stable in human saliva. OCMC was evaluated by weight uniformity, thickness, hardness, friability, swelling, mucoadhesive strength and in vitro drug release. Swelling index was higher with formulations containing hydroxypropyl methylcellulose (HPMC) K4M alone, and it decreases with its decreasing concentration in the OCMC. The in vitro drug release studies showed a release with the composition of formulation up to 12 h. The mechanism of drug release was found to be zero order kinetics with diffusion controlled drug release. It has shown significant anti-inflammatory activity (P<0.001) and no hypersensitive reaction. It can be concluded that by changing the content of OCMC system, a desire effect is generated and it overcomes the drawback associated with the conventional buccal adhesive tablet.

摘要

本研究的目的是制备并评估一种含有醋氯芬酸的渗透控释粘膜粘附杯芯制剂(OCMC)。制备OCMC时采用了一种特殊技术。在天然人唾液中测定了OCMC的稳定性,发现其pH值和制剂在人唾液中均稳定。通过重量均匀度、厚度、硬度、脆碎度、溶胀度、粘膜粘附强度和体外药物释放对OCMC进行了评估。单独含有羟丙基甲基纤维素(HPMC)K4M的制剂溶胀指数较高,其在OCMC中的浓度降低时溶胀指数会下降。体外药物释放研究表明,制剂组成在12小时内持续释放药物。发现药物释放机制为零级动力学且药物释放受扩散控制。它显示出显著的抗炎活性(P<0.001)且无过敏反应。可以得出结论,通过改变OCMC系统的含量,可以产生预期效果并克服传统口腔粘附片相关的缺点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73af/3869558/586ba14a6bb5/ijpr-09-21-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73af/3869558/1018a646276b/ijpr-09-21-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73af/3869558/04bd5d52dc71/ijpr-09-21-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73af/3869558/0ed8e2eb9752/ijpr-09-21-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73af/3869558/5350eaff1c46/ijpr-09-21-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73af/3869558/586ba14a6bb5/ijpr-09-21-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73af/3869558/1018a646276b/ijpr-09-21-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73af/3869558/04bd5d52dc71/ijpr-09-21-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73af/3869558/0ed8e2eb9752/ijpr-09-21-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73af/3869558/5350eaff1c46/ijpr-09-21-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73af/3869558/586ba14a6bb5/ijpr-09-21-g005.jpg

相似文献

1
Development of Osmotically Controlled Mucoadhesive Cup-Core (OCMC) Tablet for The Anti-Inflammatory Activity.用于抗炎活性的渗透控制型粘膜粘附杯芯(OCMC)片剂的研制
Iran J Pharm Res. 2010 Winter;9(1):21-6.
2
Preparation and evaluation of a novel buccal adhesive system.一种新型口腔黏附系统的制备与评价
AAPS PharmSciTech. 2004 Apr 29;5(3):e35. doi: 10.1208/pt050335.
3
Formulation and evaluation of mucoadhesive buccal tablets of aceclofenac.醋氯芬酸黏膜黏附口腔片的制剂与评价
Heliyon. 2021 Mar 15;7(3):e06439. doi: 10.1016/j.heliyon.2021.e06439. eCollection 2021 Mar.
4
Development and evaluation of buccal bioadhesive tablet of an anti-emetic agent ondansetron.开发和评价一种止吐药昂丹司琼的颊黏膜黏附片剂。
AAPS PharmSciTech. 2009;10(4):1085-92. doi: 10.1208/s12249-009-9304-4. Epub 2009 Sep 9.
5
Propranolol Hydrochloride Buccoadhesive Tablet: Development and Evaluation.盐酸普萘洛尔口腔黏附片:研制与评价
Iran J Pharm Res. 2020 Spring;19(2):22-33. doi: 10.22037/ijpr.2019.13866.13346.
6
Enhanced bioavailability of buspirone hydrochloride via cup and core buccal tablets: formulation and in vitro/in vivo evaluation.通过杯芯型口腔崩解片提高盐酸丁螺环酮的生物利用度:制剂及体外/体内评价
Int J Pharm. 2014 Mar 10;463(1):68-80. doi: 10.1016/j.ijpharm.2014.01.003. Epub 2014 Jan 8.
7
Development of Bioadhesive Buccal Tablets of Nicorandil Using a Factorial Approach.采用析因法开发尼可地尔生物黏附性口腔片。
Turk J Pharm Sci. 2020 Aug;17(4):388-397. doi: 10.4274/tjps.galenos.2019.09226. Epub 2020 Aug 28.
8
Preparation and pharmaceutical evaluation of glibenclamide slow release mucoadhesive buccal film.格列本脲缓释黏附性口腔膜剂的制备及药学评价
Res Pharm Sci. 2014 May-Jun;9(3):213-23.
9
Effect of Different Polymer Concentration on Drug Release Rate and Physicochemical Properties of Mucoadhesive Gastroretentive Tablets.不同聚合物浓度对黏膜黏附胃滞留片药物释放速率及理化性质的影响
Indian J Pharm Sci. 2015 Nov-Dec;77(6):705-14. doi: 10.4103/0250-474x.174993.
10
Development and evaluation of aceclofenac-loaded mucoadhesive microcapsules.载醋氯芬酸黏膜黏附微胶囊的研制与评价
J Adv Pharm Technol Res. 2011 Oct;2(4):245-54. doi: 10.4103/2231-4040.90881.

引用本文的文献

1
Formulation and evaluation of a novel matrix-type orally disintegrating Ibuprofen tablet.新型基质型布洛芬口腔崩解片的研制与评价
Iran J Pharm Res. 2011 Summer;10(3):469-79.

本文引用的文献

1
Oral pulsatile drug delivery systems.口服脉冲式给药系统
Expert Opin Drug Deliv. 2005 Sep;2(5):855-71. doi: 10.1517/17425247.2.5.855.
2
Development and evaluation of extended release formulations of isosorbide mononitrate based on osmotic technology.
Int J Pharm. 2003 Sep 16;263(1-2):9-24. doi: 10.1016/s0378-5173(03)00360-0.
3
Mucoadhesive vaginal tablets as veterinary delivery system for the controlled release of an antimicrobial drug, acriflavine.作为抗菌药物吖啶黄控释的兽用给药系统的粘膜粘附阴道片
AAPS PharmSciTech. 2002;3(3):E20. doi: 10.1208/pt030320.
4
Development of oral controlled release preparations, a PVA swelling controlled release system (SCRS). I. Design Of SCRS and its release controlling factor.口服控释制剂的研发,一种聚乙烯醇溶胀控释系统(SCRS)。I. SCRS的设计及其释药控制因素。
J Control Release. 2000 Feb 3;63(3):297-304. doi: 10.1016/s0168-3659(99)00203-5.
5
Recent advances in buccal drug delivery and absorption--in vitro and in vivo studies.口腔给药与吸收的最新进展——体外和体内研究
J Control Release. 1999 Nov 1;62(1-2):149-59. doi: 10.1016/s0168-3659(99)00032-2.
6
Evaluation of the gum from Hakea gibbosa as a sustained-release and mucoadhesive component in buccal tablets.对哈克木属植物(Hakea gibbosa)的树胶作为口腔含片的缓释和粘膜粘附成分的评价。
Pharm Dev Technol. 1999 Aug;4(3):347-58. doi: 10.1081/pdt-100101370.
7
Design, development, and biopharmaceutical properties of buccoadhesive compacts of pentazocine.
Drug Dev Ind Pharm. 1999 Jun;25(6):701-9. doi: 10.1081/ddc-100102229.
8
Plasma concentrations and bioavailability of propranolol by oral, rectal, and intravenous administration in man.普萘洛尔在人体中的口服、直肠及静脉给药后的血浆浓度和生物利用度。
Biopharm Drug Dispos. 1986 Nov-Dec;7(6):559-66. doi: 10.1002/bdd.2510070605.